Detalhe da pesquisa
1.
Long-term outcomes of neoadjuvant immunotherapy plus chemotherapy in patients with early-stage triple-negative breast cancer: an extracted individual patient data and trial-level meta-analysis.
Br J Cancer
; 130(2): 242-250, 2024 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38012381
2.
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial.
Lancet Oncol
; 24(1): 77-90, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36493792
3.
Neurovascular and hemodynamic responses to mental stress and exercise in severe COVID-19 survivors.
Am J Physiol Regul Integr Comp Physiol
; 325(3): R269-R279, 2023 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37449870
4.
Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 22(4): 499-511, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33676601
5.
Adjuvant Treatment with 5-Fluorouracil and Oxaliplatin Does Not Influence Cardiac Function, Neurovascular Control, and Physical Capacity in Patients with Colon Cancer.
Oncologist
; 25(12): e1956-e1967, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32762143
6.
Chemotherapy acutely impairs neurovascular and hemodynamic responses in women with breast cancer.
Am J Physiol Heart Circ Physiol
; 317(7): H1-H12, 2019 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31002284
7.
Return to work after breast cancer diagnosis: An observational prospective study in Brazil.
Cancer
; 124(24): 4700-4710, 2018 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30329152
8.
Adjuvant Treatment with 5-Fluorouracil and Oxaliplatin Does Not Influence Cardiac Function, Neurovascular Control, and Physical Capacity in Patients with Colon Cancer.
Oncologist
; 26(5): e907, 2021 May.
Artigo
Inglês
| MEDLINE | ID: mdl-33955124
9.
Multiagent chemotherapy for metastatic adenocarcinoma of the seminal vesicle.
Anticancer Drugs
; 25(1): 115-9, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-24113594
10.
Visceral crisis in metastatic breast cancer: an old concept with new perspectives.
Clinics (Sao Paulo)
; 79: 100362, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38754225
11.
Is my patient an appropriate candidate for sentinel node biopsy? Less axillary surgery, for the right patients. Critical review and grades of recommendation.
Surg Oncol
; 54: 102064, 2024 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38518660
12.
Global representativeness and impact of funding sources in cost-effectiveness research on systemic therapies for advanced breast cancer: A systematic review.
Breast
; 75: 103727, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38603837
13.
TROPION-Breast03: a randomized phase III global trial of datopotamab deruxtecan ± durvalumab in patients with triple-negative breast cancer and residual invasive disease at surgical resection after neoadjuvant therapy.
Ther Adv Med Oncol
; 16: 17588359241248336, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38686016
14.
Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE study.
NPJ Breast Cancer
; 10(1): 34, 2024 Apr 26.
Artigo
Inglês
| MEDLINE | ID: mdl-38671001
15.
Frequency of Radiation Therapy-Induced Malignancies in Patients With Li-Fraumeni Syndrome and Early-Stage Breast Cancer and the Influence of Radiation Therapy Technique.
Int J Radiat Oncol Biol Phys
; 2024 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38309330
16.
Contribution of tumour and immune cells to PD-L1 expression as a predictive biomarker in metastatic triple-negative breast cancer: exploratory analysis from KEYNOTE-119.
J Pathol Clin Res
; 10(3): e12371, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38627977
17.
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes.
J Clin Oncol
; 42(9): 987-993, 2024 Mar 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38194616
18.
A matched case-control study of the prognosis of early breast cancer in patients with Li-Fraumeni syndrome (BREAST TP53).
Breast
; 68: 157-162, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36773404
19.
Activity of capecitabine for central nervous system metastases from breast cancer.
Ecancermedicalscience
; 17: 1638, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-38414937
20.
Impact of pembrolizumab versus chemotherapy on health-related quality of life in patients with metastatic triple-negative breast cancer: results from the phase 3 randomised KEYNOTE-119 study.
Eur J Cancer
; 195: 113393, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37976633